The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Valsartan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valsartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valsartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valsartan include Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals and HETERO, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valsartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan.
Report Scope
The Valsartan market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
LG Life Sciences
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Segment by Application
Hypertension
Heart Failure
Heart Attack
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Valsartan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valsartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valsartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valsartan include Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals and HETERO, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valsartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan.
Report Scope
The Valsartan market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
LG Life Sciences
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Segment by Application
Hypertension
Heart Failure
Heart Attack
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Valsartan Market Overview
1.1 Product Overview and Scope of Valsartan
1.2 Valsartan Segment by Type
1.2.1 Global Valsartan Market Value Comparison by Type (2024-2030)
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Valsartan Segment by Application
1.3.1 Global Valsartan Market Value by Application: (2024-2030)
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Global Valsartan Market Size Estimates and Forecasts
1.4.1 Global Valsartan Revenue 2019-2030
1.4.2 Global Valsartan Sales 2019-2030
1.4.3 Global Valsartan Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valsartan Market Competition by Manufacturers
2.1 Global Valsartan Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valsartan Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valsartan Average Price by Manufacturers (2019-2024)
2.4 Global Valsartan Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valsartan, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valsartan, Product Type & Application
2.7 Valsartan Market Competitive Situation and Trends
2.7.1 Valsartan Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valsartan Players Market Share by Revenue
2.7.3 Global Valsartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valsartan Retrospective Market Scenario by Region
3.1 Global Valsartan Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valsartan Global Valsartan Sales by Region: 2019-2030
3.2.1 Global Valsartan Sales by Region: 2019-2024
3.2.2 Global Valsartan Sales by Region: 2025-2030
3.3 Global Valsartan Global Valsartan Revenue by Region: 2019-2030
3.3.1 Global Valsartan Revenue by Region: 2019-2024
3.3.2 Global Valsartan Revenue by Region: 2025-2030
3.4 North America Valsartan Market Facts & Figures by Country
3.4.1 North America Valsartan Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valsartan Sales by Country (2019-2030)
3.4.3 North America Valsartan Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Valsartan Market Facts & Figures by Country
3.5.1 Europe Valsartan Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valsartan Sales by Country (2019-2030)
3.5.3 Europe Valsartan Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valsartan Market Facts & Figures by Country
3.6.1 Asia Pacific Valsartan Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valsartan Sales by Country (2019-2030)
3.6.3 Asia Pacific Valsartan Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Valsartan Market Facts & Figures by Country
3.7.1 Latin America Valsartan Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valsartan Sales by Country (2019-2030)
3.7.3 Latin America Valsartan Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valsartan Market Facts & Figures by Country
3.8.1 Middle East and Africa Valsartan Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valsartan Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valsartan Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valsartan Sales by Type (2019-2030)
4.1.1 Global Valsartan Sales by Type (2019-2024)
4.1.2 Global Valsartan Sales by Type (2025-2030)
4.1.3 Global Valsartan Sales Market Share by Type (2019-2030)
4.2 Global Valsartan Revenue by Type (2019-2030)
4.2.1 Global Valsartan Revenue by Type (2019-2024)
4.2.2 Global Valsartan Revenue by Type (2025-2030)
4.2.3 Global Valsartan Revenue Market Share by Type (2019-2030)
4.3 Global Valsartan Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valsartan Sales by Application (2019-2030)
5.1.1 Global Valsartan Sales by Application (2019-2024)
5.1.2 Global Valsartan Sales by Application (2025-2030)
5.1.3 Global Valsartan Sales Market Share by Application (2019-2030)
5.2 Global Valsartan Revenue by Application (2019-2030)
5.2.1 Global Valsartan Revenue by Application (2019-2024)
5.2.2 Global Valsartan Revenue by Application (2025-2030)
5.2.3 Global Valsartan Revenue Market Share by Application (2019-2030)
5.3 Global Valsartan Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Valsartan Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Corporation Information
6.2.2 Sun Pharmaceutical Description and Business Overview
6.2.3 Sun Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharmaceutical Valsartan Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Valsartan Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Valsartan Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Corporation Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alembic Pharmaceuticals Valsartan Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lupin Valsartan Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Valsartan Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Macleods Pharmaceuticals
6.8.1 Macleods Pharmaceuticals Corporation Information
6.8.2 Macleods Pharmaceuticals Description and Business Overview
6.8.3 Macleods Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Macleods Pharmaceuticals Valsartan Product Portfolio
6.8.5 Macleods Pharmaceuticals Recent Developments/Updates
6.9 HETERO
6.9.1 HETERO Corporation Information
6.9.2 HETERO Description and Business Overview
6.9.3 HETERO Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.9.4 HETERO Valsartan Product Portfolio
6.9.5 HETERO Recent Developments/Updates
6.10 Torrent Pharmaceuticals
6.10.1 Torrent Pharmaceuticals Corporation Information
6.10.2 Torrent Pharmaceuticals Description and Business Overview
6.10.3 Torrent Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Torrent Pharmaceuticals Valsartan Product Portfolio
6.10.5 Torrent Pharmaceuticals Recent Developments/Updates
6.11 Huaren Pharmaceutical
6.11.1 Huaren Pharmaceutical Corporation Information
6.11.2 Huaren Pharmaceutical Valsartan Description and Business Overview
6.11.3 Huaren Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huaren Pharmaceutical Valsartan Product Portfolio
6.11.5 Huaren Pharmaceutical Recent Developments/Updates
6.12 Jubilant Pharma
6.12.1 Jubilant Pharma Corporation Information
6.12.2 Jubilant Pharma Valsartan Description and Business Overview
6.12.3 Jubilant Pharma Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jubilant Pharma Valsartan Product Portfolio
6.12.5 Jubilant Pharma Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Corporation Information
6.13.2 Amneal Pharmaceuticals Valsartan Description and Business Overview
6.13.3 Amneal Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Amneal Pharmaceuticals Valsartan Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 Zhejiang Huahai Pharmaceutical
6.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.14.2 Zhejiang Huahai Pharmaceutical Valsartan Description and Business Overview
6.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio
6.14.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.15 Square Pharmaceuticals
6.15.1 Square Pharmaceuticals Corporation Information
6.15.2 Square Pharmaceuticals Valsartan Description and Business Overview
6.15.3 Square Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Square Pharmaceuticals Valsartan Product Portfolio
6.15.5 Square Pharmaceuticals Recent Developments/Updates
6.16 Unichem Laboratories
6.16.1 Unichem Laboratories Corporation Information
6.16.2 Unichem Laboratories Valsartan Description and Business Overview
6.16.3 Unichem Laboratories Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Unichem Laboratories Valsartan Product Portfolio
6.16.5 Unichem Laboratories Recent Developments/Updates
6.17 LG Life Sciences
6.17.1 LG Life Sciences Corporation Information
6.17.2 LG Life Sciences Valsartan Description and Business Overview
6.17.3 LG Life Sciences Valsartan Sales, Revenue and Gross Margin (2019-2024)
6.17.4 LG Life Sciences Valsartan Product Portfolio
6.17.5 LG Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valsartan Industry Chain Analysis
7.2 Valsartan Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valsartan Production Mode & Process
7.4 Valsartan Sales and Marketing
7.4.1 Valsartan Sales Channels
7.4.2 Valsartan Distributors
7.5 Valsartan Customers
8 Valsartan Market Dynamics
8.1 Valsartan Industry Trends
8.2 Valsartan Market Drivers
8.3 Valsartan Market Challenges
8.4 Valsartan Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Valsartan Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Valsartan Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Valsartan Market Competitive Situation by Manufacturers in 2023
Table 4. Global Valsartan Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Valsartan Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Valsartan Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Valsartan Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Valsartan Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Valsartan, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Valsartan, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Valsartan, Product Type & Application
Table 12. Global Key Manufacturers of Valsartan, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Valsartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Valsartan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Valsartan Sales by Region (2019-2024) & (K Units)
Table 18. Global Valsartan Sales Market Share by Region (2019-2024)
Table 19. Global Valsartan Sales by Region (2025-2030) & (K Units)
Table 20. Global Valsartan Sales Market Share by Region (2025-2030)
Table 21. Global Valsartan Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Valsartan Revenue Market Share by Region (2019-2024)
Table 23. Global Valsartan Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Valsartan Revenue Market Share by Region (2025-2030)
Table 25. North America Valsartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Valsartan Sales by Country (2019-2024) & (K Units)
Table 27. North America Valsartan Sales by Country (2025-2030) & (K Units)
Table 28. North America Valsartan Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Valsartan Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Valsartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Valsartan Sales by Country (2019-2024) & (K Units)
Table 32. Europe Valsartan Sales by Country (2025-2030) & (K Units)
Table 33. Europe Valsartan Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Valsartan Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Valsartan Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Valsartan Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Valsartan Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Valsartan Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Valsartan Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Valsartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Valsartan Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Valsartan Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Valsartan Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Valsartan Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Valsartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Valsartan Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Valsartan Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Valsartan Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Valsartan Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Valsartan Sales (K Units) by Type (2019-2024)
Table 51. Global Valsartan Sales (K Units) by Type (2025-2030)
Table 52. Global Valsartan Sales Market Share by Type (2019-2024)
Table 53. Global Valsartan Sales Market Share by Type (2025-2030)
Table 54. Global Valsartan Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Valsartan Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Valsartan Revenue Market Share by Type (2019-2024)
Table 57. Global Valsartan Revenue Market Share by Type (2025-2030)
Table 58. Global Valsartan Price (US$/Unit) by Type (2019-2024)
Table 59. Global Valsartan Price (US$/Unit) by Type (2025-2030)
Table 60. Global Valsartan Sales (K Units) by Application (2019-2024)
Table 61. Global Valsartan Sales (K Units) by Application (2025-2030)
Table 62. Global Valsartan Sales Market Share by Application (2019-2024)
Table 63. Global Valsartan Sales Market Share by Application (2025-2030)
Table 64. Global Valsartan Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Valsartan Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Valsartan Revenue Market Share by Application (2019-2024)
Table 67. Global Valsartan Revenue Market Share by Application (2025-2030)
Table 68. Global Valsartan Price (US$/Unit) by Application (2019-2024)
Table 69. Global Valsartan Price (US$/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Valsartan Product
Table 74. Novartis Recent Developments/Updates
Table 75. Sun Pharmaceutical Corporation Information
Table 76. Sun Pharmaceutical Description and Business Overview
Table 77. Sun Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sun Pharmaceutical Valsartan Product
Table 79. Sun Pharmaceutical Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Valsartan Product
Table 84. Teva Recent Developments/Updates
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Mylan Valsartan Product
Table 89. Mylan Recent Developments/Updates
Table 90. Alembic Pharmaceuticals Corporation Information
Table 91. Alembic Pharmaceuticals Description and Business Overview
Table 92. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Alembic Pharmaceuticals Valsartan Product
Table 94. Alembic Pharmaceuticals Recent Developments/Updates
Table 95. Lupin Corporation Information
Table 96. Lupin Description and Business Overview
Table 97. Lupin Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lupin Valsartan Product
Table 99. Lupin Recent Developments/Updates
Table 100. Aurobindo Pharma Corporation Information
Table 101. Aurobindo Pharma Description and Business Overview
Table 102. Aurobindo Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Aurobindo Pharma Valsartan Product
Table 104. Aurobindo Pharma Recent Developments/Updates
Table 105. Macleods Pharmaceuticals Corporation Information
Table 106. Macleods Pharmaceuticals Description and Business Overview
Table 107. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Macleods Pharmaceuticals Valsartan Product
Table 109. Macleods Pharmaceuticals Recent Developments/Updates
Table 110. HETERO Corporation Information
Table 111. HETERO Description and Business Overview
Table 112. HETERO Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. HETERO Valsartan Product
Table 114. HETERO Recent Developments/Updates
Table 115. Torrent Pharmaceuticals Corporation Information
Table 116. Torrent Pharmaceuticals Description and Business Overview
Table 117. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Torrent Pharmaceuticals Valsartan Product
Table 119. Torrent Pharmaceuticals Recent Developments/Updates
Table 120. Huaren Pharmaceutical Corporation Information
Table 121. Huaren Pharmaceutical Description and Business Overview
Table 122. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Huaren Pharmaceutical Valsartan Product
Table 124. Huaren Pharmaceutical Recent Developments/Updates
Table 125. Jubilant Pharma Corporation Information
Table 126. Jubilant Pharma Description and Business Overview
Table 127. Jubilant Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Jubilant Pharma Valsartan Product
Table 129. Jubilant Pharma Recent Developments/Updates
Table 130. Amneal Pharmaceuticals Corporation Information
Table 131. Amneal Pharmaceuticals Description and Business Overview
Table 132. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Amneal Pharmaceuticals Valsartan Product
Table 134. Amneal Pharmaceuticals Recent Developments/Updates
Table 135. Zhejiang Huahai Pharmaceutical Corporation Information
Table 136. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 137. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Zhejiang Huahai Pharmaceutical Valsartan Product
Table 139. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 140. Square Pharmaceuticals Corporation Information
Table 141. Square Pharmaceuticals Description and Business Overview
Table 142. Square Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Square Pharmaceuticals Valsartan Product
Table 144. Square Pharmaceuticals Recent Developments/Updates
Table 145. Unichem Laboratories Corporation Information
Table 146. Unichem Laboratories Description and Business Overview
Table 147. Unichem Laboratories Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Unichem Laboratories Valsartan Product
Table 149. Unichem Laboratories Recent Developments/Updates
Table 150. LG Life Sciences Corporation Information
Table 151. LG Life Sciences Description and Business Overview
Table 152. LG Life Sciences Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. LG Life Sciences Valsartan Product
Table 154. LG Life Sciences Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Valsartan Distributors List
Table 158. Valsartan Customers List
Table 159. Valsartan Market Trends
Table 160. Valsartan Market Drivers
Table 161. Valsartan Market Challenges
Table 162. Valsartan Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Valsartan
Figure 2. Global Valsartan Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Valsartan Market Share by Type in 2023 & 2030
Figure 4. 40 mg Tablets Product Picture
Figure 5. 80 mg Tablets Product Picture
Figure 6. 160 mg Tablets Product Picture
Figure 7. 320 mg Tablets Product Picture
Figure 8. Global Valsartan Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Valsartan Market Share by Application in 2023 & 2030
Figure 10. Hypertension
Figure 11. Heart Failure
Figure 12. Heart Attack
Figure 13. Global Valsartan Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Valsartan Market Size (2019-2030) & (US$ Million)
Figure 15. Global Valsartan Sales (2019-2030) & (K Units)
Figure 16. Global Valsartan Average Price (US$/Unit) & (2019-2030)
Figure 17. Valsartan Report Years Considered
Figure 18. Valsartan Sales Share by Manufacturers in 2023
Figure 19. Global Valsartan Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Valsartan Players: Market Share by Revenue in 2023
Figure 21. Valsartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Valsartan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Valsartan Sales Market Share by Country (2019-2030)
Figure 24. North America Valsartan Revenue Market Share by Country (2019-2030)
Figure 25. United States Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Valsartan Sales Market Share by Country (2019-2030)
Figure 28. Europe Valsartan Revenue Market Share by Country (2019-2030)
Figure 29. Germany Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Valsartan Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Valsartan Revenue Market Share by Region (2019-2030)
Figure 36. China Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Valsartan Sales Market Share by Country (2019-2030)
Figure 46. Latin America Valsartan Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Valsartan Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Valsartan Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Valsartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Valsartan by Type (2019-2030)
Figure 56. Global Revenue Market Share of Valsartan by Type (2019-2030)
Figure 57. Global Valsartan Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Valsartan by Application (2019-2030)
Figure 59. Global Revenue Market Share of Valsartan by Application (2019-2030)
Figure 60. Global Valsartan Price (US$/Unit) by Application (2019-2030)
Figure 61. Valsartan Value Chain
Figure 62. Valsartan Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
